References
- Blum A, Stöltzing H, Bauerfeind P. Decisions in a case of upper G.I. hemorrhage. Data analysis for clinical medicine: the quantitative approach to patient care in gastroenterology, T Chalmers. International University Press, Rome 1988; 145–74
- Cook DJ, Guyatt GH, Salena BJ, Laine LA. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 1992; 102: 139–48
- Collins R, Langman M. Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials. N Engl J Med 1985; 313: 660–6
- Walt RP, Cottrell J, Mann SG, Freemantle NP, Langman MJ. Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet 1992; 340: 1058–62
- Daneshmend TK, Hawkey CJ, Langman MJ, Logan RF, Long RG, Walt RP. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. Br Med J 1992; 304: 143–7
- Brunner G, Chang J. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal trace: an open randomized controlled trial. Digestion 1990; 45: 217–25
- Chaimoff C, Creter D, Djaldetti M. The effect of pH on platelet and coagulation factor activities. Am J Surg 1978; 136: 257–9
- Flatow FA, Freireich EJ. The increased effectiveness of platelet concentrates prepared in acidified plasma. Blood 1966; 27: 449–59
- Green FJ, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978; 74: 38–43
- Piper D, Fenton B. pH stability and activity curves of pepsin with special reference to their clinical importance. Gut 1965; 6: 506–8
- Berstad A. A modified hemoglobin substrate method for the estimation of pepsin in gastric juice. Scand J Gastroenterol 1970; 5: 343–8
- Merki HS, Witzel L, Kaufman D. Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer. Gut 1988; 29: 453–7
- Cederberg C, Thompson ABR, Kirdeikis P, Kristersson C. Effect of continuous intravenous infusion of omeprazole on 24-hour intragastric pH in fasting DU-patients: comparison to repeated bolus doses of omeprazole or ranitidine. Gastroenterology 1992; 102: A48
- Lind T, Moore M, Olbe L. Intravenous omeprazole: effect on 24-hour intragastric pH in duodenal ulcer patients. Digestion 1986; 34: 78–86
- Nielsen J, Ström M, Fernström P. Effect of continuous infusion of omeprazole and ranitidine on intragastric acidity [abstract]. Scand J Gastroenterol 1990; 25: 95, Suppl 176
- Cederberg C, Bergstrand R. Continuous intravenous-infusion of omeprazole effectively controls intragastric pH even during pentagastrin challenge. The World Congress of Gastroenterology, SydneyAustralia 1990
- Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974; 2: 394–7
- Merki HS, Wilder-Smith C. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing. Gastroenterology 1994; 106: 60–4
- Kiilerich S, Rannem T, Elsborg L. Effect of intravenous omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer. Digestion 1995; 56: 25–30
- Sérrano De Acéro A. Hemorragia digestiva superior en pacientes mayores de 60 anos. Rev Soc Venezol Gastroenterol 1993; 47: 53–6
- Pimpl W, Boeckl O, Waclawiczek HW, Heinerman M. Estimation of the mortality rate of patients with severe gastroduodenal hemorrhage with the aid of a new scoring system. Endoscopy 1987; 19: 101–6
- Branicki FJ, Boey J, Fok PJ. Bleeding gastric ulcer: a prospective evaluation of rebleeding and mortality. Aust NZ J Surg 1989; 59: 551–62
- Branicki FJ, Boey J, Fok PJ. Bleeding duodenal ulcer. A prospective evaluation of risk factors for rebleeding and death. Ann Surg 1990; 211: 411–8
- Wheatley KE, Snyman JH, Brearley S, Keighley MR, Dykes PW. Mortality in patients with bleeding peptic ulcer when those aged 60 or over are operated on early. Br Med J 1990; 301: 272
- Goletti O, Sidoti F, Lippolis PV, De Negri F, Cavina E. Omeprazole versus ranitidine plus somatostatin in the treatment of severe gastroduodenal bleeding: a prospective, randomized, controlled trial. Ital J Gastroenterol 1994; 26: 72–4
- Kohler B, Benz C, Maier M, Knobloch M, Riemann JF. Gastric pH-monitoring in patients with acute ulcer bleeding under continuous intravenous therapy with omeprazole (om) or ranitidine (ran). Gastroenterology 1994; 106: A 109
- Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J. The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors. Gastrointest Endosc 1981; 27: 80–93
- Branicki FJ, Coleman SY, Fok PJ. Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg 1990; 14: 262–9, discussion 269–70.
- The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029–35
- Hennekens CH, Buring JE, Peto R. Antioxidant vitamins—benefits not yet proved [editorial]. N Engl J Med 1994; 330: 1080–1
- Friedman LS, Martin P. The problem of gastrointestinal bleeding. Gastroenterol Clin North Am 1993; 22: 717–21